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SUPPRESSOR CELL FUNCTION IN THYROID AUTOIMMUNE DISEASE IS AFFECTED 
BY PLASMID ENCODED PROTEINS OF ENTEROPATHOCENIC YERSINIA 
B.E. WENZEL-; J . HE ES EM ANN-** ; S . GRAMMERSTORF * ; P.C. SCRIBA* 
D e p t . I n t e r n a l M e d i c i n e , M e d . U n i v e r s i t y Lübeck* and I n s t . M i e r o b i o l . & 
Immunol., U n i v e r s i t y Hamburg, FR Germany 
INTRODUCTION 
Autoimmune t h y r o i d d i s e a s e ( A I T D ) and Y e r s i n i a e n t e r o e o l i t i c a ( Y . e . ) 
show s t r i k i n g c r o s s r e a c t i v i t i e s o f humoral and c e l l u l a r immunity 
( 1 , 2 , 3 ) . S i n c e Y.e. a l s o has b i n d i n g s i t e s f o r t h y r o t r o p h i n T S H ) . t h e 
r o l e Y.e. might p l a y f o r the p a t h o g e n i s i s of AITD became a m a t t e r 
of i n t e r e s t . R e c e n t l y i t became e v i d e n t t h a t a p r e - r e q u i s i t e of 
v i r u l e n c e i n e n t e r o p a t h o g e n i c Y . e . - i n f e c t i o n s i s the presence o f a 
4 2 - 4 6 MDa p l a s m i d which i s r a p i d l y l o s t a f t e r s u b c u l t i v a t i o n ( 4 ) . 
T h i s p l a s m i d mediates v i r u l e n c e f u n c t i o n s such as serum- and phago 
c y t o s i s r e s i s i t a n c e or c e l l a d h e r e n c e ( 5 ) • The p l a s m i d a l s o encodes 
f o r at l e a s t 6 p r o t e i n s a g a i n s t which humans and a n i m a l s produce 
a n t i b o d i e s a f t e r Y . e . - i n f e c t i o n s . In c a l c i u m d e f i c i e n t c u l t u r e 
medium thevSe immunogenic r e l e a s e - p r o t e i n s (RPs) a r e s e c r e t e d i n h i g h 
q u a n t i t i e s ( 6 ) . 
We r e c e n t l y r e p o r t e d t h a t p a t i e n t s w i t h AITD have h i g h f r e q u e n c i e s 
of R P - a n t i b o d i e s of IgM,IgA and IgG c l a s s as w e l l as a n t i b o d i e s t o 
a 25 kDa RP.This 25 kDa RP shows a n t i g e n i c homologies w i t h the TSH-
r e e e p t o r ( 7 ) • M o r o o v e r , i n G r a v e s v d i s e a s e ( G D ) a n t i b o d i e s t o the 25 
kDa RP and a n t i b o d i e s of IgA c l a s s emerge e a r l y at the onset o f the 
d i s e a s e but l a t e r than the T S H - r e c e p t o r a n t i b o d i e s are d e t e c t e d i n 
p a t i e n t s * b1o o d ( 8) . W i t h i n 12 mo nt h s t he re a f t e r t hes e a n t i bo di e s 
v a n i s h ( 9 ) • 
S i n c e b a c t e r i a c a r r y i n g the p l a s m i d äffect some p r o p e r t i e s o f 
macrophages,i.c. c e l l adherence and p a g o c y t o s i s r e s i s t a n c e ( 5 ) 5 we 
now i n v e s t i g a t e the f u n c t i o n a l e f f e c t the RPs and Y.e.-
plasma membranes(YOP) might have on the immnune s u r v e i l l a n c e i n 
p a t i e n t s with AITD. In the p r e s e n t study we l o o k e d at the e f f e c t 
of RPs and of Y.e.-plasma membranes on lymphocyte S t i m u l a t i o n w i t h 
an im re 1a t ed an t i gen,t etanus toxo i d a n t i g e n ( T T A ) . 
MATERIAL AND METHODS 
P a t i e n t s p r o f i l e 
P a t i e n t s with G r a v e s " h y p e r t h y r o i d i s m and normal i n d i v i d u a l s who 
p r e v i o u s l y had been s e n s i t i z o d t o TTA were a s s e s s e d f o r RP 
ant i 1)od i es. A l l GD pa t i e n t s ( n - 5 ) were R P an t ibody p o s i t i vo and had 
TSH-receptor a n t i b o d i e s . I f t h e i r l a s t TIA v a c c i n a t i o n was more 
than 2 y e a r s ago,tho i n d i v i d u a l s were r e - s e n s i t i z e d w i th t h e i r 
c o n sent. 
Lvmphoeyle f r a c t i o n s 
H e p a r i n i z e d p e r i p h e r a l b l o o d was s u b m i t t e d t o F i c a l l d e n s i t y 
c e n t r i f u g a t i o n . The lymphocyte f r a c t i o n (PBL) was suspended w i t h 
sheep red blood c e l l s ( S R B C ) . The s p o n t a n e o u s l y formecl r o s e t t e s ( S R B C -
R) were s e p a r a t e d from n o n . T - c e l l s on F i c o l l and f i n a l l y the SRBC 
were l y s e d with water. One p a r t o f PBLs was p l a t e d f o r 2 hours i n 
p l a s t i c d i s h e s with complcte RPMI 1640 medium wi t h 2 0 % f e t a l c a l f 
serum(FCS). The adherent c e l l s and the non-adherent lymphocytes 
were c o l l e c t e d , c o u n t e d and s t o r e d f o r the r e c o n s t i t u t i o n e x p e r i -
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ments. The y i e l d of adherent macrophages (/)M) v a r i e d from 2-4% of 
the i n i t i a l PBLs. 
A n t i g e n s 
TTA was k i n d l y p r o v i d e d by BEHRING SA,Marburg.FRG. The S t a n d a r d 
c o n c e n t r a t i o n used was 2Lf/ml TTA. Y.e.-RPs were s e p a r a t e d from the 
c a l c i u m d e f i c i e n t medium by u l t r a f i l t r a t i o n ( A M I C O N , P M 1 0 ) .RPs were 
resuspended by s o n i f i c a t i o n and passed through a 0 . 4 5 p s t e r i l e 
f i l t e r . The Y . e . - s e r o p t y p e s used were 0 : 3 and 0 : 9 s t r a i n s . In 
lymphocyte c u l t u r e s RPs were used at lOOng/ml f i n a l c o n c e n t r a t i o n . 
For the p r e p a r a t i o n of b a c t e r i a l o u t e r membrancs(YOP), membranes 
were d i s r u p t e d by s o n i c l y s i s ( 1 0 ) . The membranes were 
w a s h e d , e x t e n s i v e l y s o n i c a t e d and passed t h r o u g h a 0 . 4 5 h f i l t e r . The 
p r o t e i n which passed the f i l t e r was used at lOng/ml f i n a l 
c o n c e n t r a t i o n . 
When i n d i c a t e d , indomethacin(IM) was a p p l i e d at l - 1 0 n g/ml. 
Lymphocyte c u l t u r e s 
C e l l s were c u l t u r e d i n 96 w e l l p l a t e s , 5 w q e l l per sample. The 
complete c u l t u r e medium c o n t a i n e d 10$ FCS. Lymphocytes were used at 
1.5*10^ c e l l s / m l . When i n d i c a t e d , 2 % adherent </M were added. 
Lymphocytes were c u l t u r e d f o r 6 days w i t h TTA w i t h or w i t h o u t 
a d d i n g : JjM, RPs , YOPs , IM. For the l a s t 24 hours 0 . 5 p C i/ml 3 h_thymidine 
( 3 H - T d R ) . T h e r e a f t e r , c e l l s were c o l l e c t e d w i t h an automated 
c e l l h a r v e s t e r a p p l y i n g the sequence watcr,TCA 10%,et hano 1.Samples 
were counted i n a s c i n t i I I a t i o n c o u n t e r and c a l c u l a t e d as S t i m u l a -
t i o n i n d c x ( S I ) ± S t a n d a r d d e v i a t i o n ( S D ) . S t i m u l a t i o n or i n h i b i t i o n 
of the TTA response were e x p r e s s e d as % of the S t i m u l a t i o n w i th ITA 




F i g u r e 1 : I' f f e c t 
of Y . e . - p l a s m i d 
e n c o d e d a n t i g e n s 
on the TTA r e -
sponse of normal 
p e r i p h e r a l b l o o d 
lymphocytes. 
RP R e l e a s e Pro-
t e i n s , M P YOP 
from Y . e . w i t \\ / 
M(f without 
p l a s m i d , 
mac rophage s, 
T T-1ymphocy t e s, 
T^ t e t a n u s t o \ o i d 
ant i gen. 
RESULTS 
F i g u r e 1 shows how the RPs are s u p p r e s s i n g the TTA response of 
normal PBLs( 7 0 % + 4,n-5,P < 0 . 05) • Y O P - f r a c t i o n s , h o w e v e r , d o not äffect 
the TTA S t i m u l a t i o n , r e g a r d l e s s l y of whether they d e r i v e from 
b a c t e r i a w i t h plasmid(M-P) or w i t h o u t ( M 0 ) . A s i m i l a r p a t t e r n i s 
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found w i t h T - c e l l s r e c o n s t i t u t e d w i t h macrophages(^M). In the 
absence of macrophages the RPs do not i n f l u e n c e the TTA response of 
T-lymphocytes. In c o n t r a s t , P B L s from p a t i e n t s w i t h GD are not 
a f f e c t e d by RPs which o n l y produce an i n s i g n i f i c a n t r e d u c t i o n of 
the TTA r e s p o n s e ( F i g u r e 2 ) . The YOPs,however, produce an excess 
S t i m u l a t i o n . 
F i g u r e 3 demonstrates t h a t t h e s u p p r e s s i v e potency of RPs i s 
macrophage dependent. D e p l e t i o n of PBLs from macrophages or 
a d m i n i s t r a t i o n of indömethacin(IM) a b o l i s h e s the s u p p r e s s i o n of the 
TTA response w i t h normal PBLs. 
CONCLUSIONS 
Our e x p e r i m e n t s show f o r the f i r s t time t h a t the p l a s m i d of 
e n t e r o p a t h o g e n i c Y.e. does i n t e r f e r e through i t s p r o t e i n p r o d u c t s 
w i t h the immune s u r v e i l l a n c e i n normal i n d i v i d u a l s . The s u p p r e s s i v e 
e f f e c t of RPs on t h e TTA response i s e x e r t e d on the adherent 
macrophages. The e f f e c t on the T - c e l l p r o l i f e r a t i o n appears to be 
mediated by P r o s t a g l a n d i n s , s i n c e the c y c l o - o x y g e n a s e b l o c k e r , I M , 
a b o l i s h e s the s u p p r e s s i o n . A l t h o u g h p h a g o c y t o s i s r e s i s i t a n c e and 
c e l l adherence o f e n t e r o p a t h o g e n i c Y.e. are a t t r i b u t e d t o the 
p l a s m i d encoded Y0P1 a n t i g e n , o u r membrane f r a c t i o n s d i d not 
sup p r e s s the TTA r e s p o n s e . In c o n s t r a s t , b o t h ,membranes from Y.e. 
with or w i t h o u t p l a s m i d , s t i m u l a t e d lymphocytes from p a t i e n t s with 
GD,who were p r e - s e n s i t i z e d by Y.e.(RP-antibody p o s i t i v e ) . T h i s may 
i n d i c a t e t h a t the p l a s m i d dependent(YOP 1) s u p p r e s s i v e e f f e c t i s 
c o u n t e r a c t e d by the s t i m u l a t o r y p r o p e r t i e s of the membrane 
1 i p o p r o t e i n s ( 1 0 ) . The macrophages i n GD appear not t o r e a c t t o the 
RPs,although p h a g o c y t o s i s r e s i s t a n c e i s p l a s m i d encoded(5)» 
rfi 
RP M-P M-* 
T*0M 
n=5 
RP M-P M » 
T 
n=5 
F i g u r e 2: E f f e c t 
of Y.e.-p1a sm i d 
encoded a n t i g e n s 
on the TTA r e -
sponse of PBLs 
from p a t i e n t s 
with GD. 
RP- Rele a s e Pro-
t e i n s ,M-P -YOP 
from Y.e. wi t h 
/M-0 wit h o u t 
p l a s m i d 
^M^macrophages; 
T= T-lymphocytes 
TTA- t e t a n u s 
t o x o i d a n t i g e n 
T h i s c o u l d mean t h a t macrophages are rendered i n a c t i v e by RPs.Hence, 
b a c t e r i a can not be e l i m i n a t e d t h r o u g h p h a g o c y t o s i s and a l a t e n t or 
c h r o n i c i n f e c t i o n might r e s u l t . T h i s s c e n a r i o would be r e f l e c t e d 
by the p e r s i s t i n g h i g h p r e v a l e n c e of Y . e . - a n t i b o d i e s i n GD-
p a t i e n t s ( 8 ) . In g e n e t i c a l l y committed i n d i v i d u a l s a n t i g e n i c mimery 
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o f RPs with t h y r o i d a n t i g e n s ( 7 ) would l e a d t o the break of s e l f -
t o l e r a n c e and the developement o f AITD. These a r e , o f 
c o u r s e , h y p o t h e t i c a l c o n s i d e r a t i o n s , s i n c e i n our System the Y.e.-RPs 
are s e c r e t e d under n o n - p h y s o i l o g i c a l c o n d i t i o n s , i . e . c a l c i u m 
d e f i c i e n c y . F u r t h e r i n v e s t i g a t i o n s w i l l show what s i g n i f i c a n c e RPs 
might have i n v i v o . 
F i g u r e ?: E f f e c t of 
indömethacin on the RP 
mediated s u p p r e s s i o n of 
the TTA response w i t h 
normal PBLs. 
RP- R e l e a s e P r o t e i n s 
TTA= t e t a n u s t o x o i d 
antigen;oM- macrophages 
IM- indömethacin 
TTA + R P * T-CELLS 
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